Page last updated: 2024-10-30

vitamin k 3 and Liver Neoplasms

vitamin k 3 has been researched along with Liver Neoplasms in 12 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Vitamin K5 was shown to suppress the proliferation of PLC/PRF/5 cells at a concentration of 30 microM."1.33In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma. ( Deguchi, A; Hitomi, M; Inoue, H; Kimura, Y; Kuriyama, S; Kurokohchi, K; Masaki, T; Nakai, S; Nonomura, T; Ogawa, M; Uchida, N; Yokoyama, F; Yoshiji, H, 2005)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's0 (0.00)18.2507
2000's9 (75.00)29.6817
2010's1 (8.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Dawood, M1
Hegazy, MF1
Elbadawi, M1
Fleischer, E1
Klinger, A1
Bringmann, G1
Kuntner, C1
Shan, L1
Efferth, T1
Hendrickx, DM1
Jennen, DG1
Briedé, JJ1
Cavill, R1
de Kok, TM1
Kleinjans, JC1
Matzno, S1
Yamaguchi, Y1
Akiyoshi, T1
Nakabayashi, T1
Matsuyama, K1
Andreassen, K1
Mortensen, B1
Winberg, JO1
Huseby, NE1
MIURA, Y1
ASO, Y1
MASHIMA, Y1
NAGATA, I1
Park, SY1
Chang, I1
Kim, JY1
Kang, SW1
Park, SH1
Singh, K1
Lee, MS1
Verrax, J1
Cadrobbi, J1
Marques, C1
Taper, H1
Habraken, Y1
Piette, J1
Calderon, PB1
Hitomi, M2
Yokoyama, F2
Kita, Y1
Nonomura, T2
Masaki, T2
Yoshiji, H2
Inoue, H2
Kinekawa, F1
Kurokohchi, K2
Uchida, N2
Watanabe, S1
Kuriyama, S2
Ogawa, M1
Nakai, S1
Deguchi, A1
Kimura, Y1
Collins, P1
Jones, C1
Choudhury, S1
Damelin, L1
Hodgson, H1
Sarin, SK1
Kumar, M1
Garg, S1
Hissar, S1
Pandey, C1
Sharma, BC1
Kar, S1
Wang, M1
Ham, SW1
Carr, BI1

Trials

1 trial available for vitamin k 3 and Liver Neoplasms

ArticleYear
High dose vitamin K3 infusion in advanced hepatocellular carcinoma.
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:9

    Topics: Adult; Antifibrinolytic Agents; Carcinoma, Hepatocellular; Humans; Kaplan-Meier Estimate; Liver Neop

2006

Other Studies

11 other studies available for vitamin k 3 and Liver Neoplasms

ArticleYear
Vitamin K
    Biochemical pharmacology, 2020, Volume: 180

    Topics: Animals; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Aggregation; Cell Survival; Dose-Resp

2020
Pattern recognition methods to relate time profiles of gene expression with phenotypic data: a comparative study.
    Bioinformatics (Oxford, England), 2015, Jul-01, Volume: 31, Issue:13

    Topics: Antifibrinolytic Agents; Benzo(a)pyrene; Carcinoma, Hepatocellular; Computer Simulation; Gene Expres

2015
An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents.
    Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; Cell Line, Tumo

2008
Increased resistance towards oxidative stress accompanies enhancement of metastatic potential obtained by repeated in vivo passage of colon carcinoma cells in syngeneic rats.
    Clinical & experimental metastasis, 2002, Volume: 19, Issue:7

    Topics: Adaptation, Physiological; Animals; Apoptosis; Carcinoma; Cell Adhesion; Cell Division; Collagen; Co

2002
Studies on the metabolism of rat-ascites-tumor with nitrogen mustard sensitive and resistant strains. VII. Effect of ubiquinone a vitamin K3 on succinate- and alpha-glyceropnosphate-neotetrazolium reductase.
    Journal of biochemistry, 1962, Volume: 52

    Topics: Animals; Ascites; Carcinoma, Hepatocellular; Coenzymes; Electron Transport Complex II; Liver Neoplas

1962
Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase.
    The Journal of biological chemistry, 2004, Feb-27, Volume: 279, Issue:9

    Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; DNA, Mitochondrial; Doxorubicin; D

2004
Ascorbate potentiates the cytotoxicity of menadione leading to an oxidative stress that kills cancer cells by a non-apoptotic caspase-3 independent form of cell death.
    Apoptosis : an international journal on programmed cell death, 2004, Volume: 9, Issue:2

    Topics: Animals; Antioxidants; Ascorbic Acid; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Death; Li

2004
Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
    International journal of oncology, 2005, Volume: 26, Issue:3

    Topics: Animals; Antifibrinolytic Agents; Carcinoma, Hepatocellular; Cell Cycle; Drug Screening Assays, Anti

2005
In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma.
    International journal of oncology, 2005, Volume: 26, Issue:5

    Topics: Animals; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Down-Regulation; G1 Phase; Humans; Liv

2005
Increased expression of uncoupling protein 2 in HepG2 cells attenuates oxidative damage and apoptosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:4

    Topics: Antifibrinolytic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Hepat

2005
H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
    Cancer biology & therapy, 2006, Volume: 5, Issue:10

    Topics: Animals; Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Cycle Proteins; Cell Division; Cell Lin

2006